Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Wisconsin, Madison
With
American Cancer Society, Inc.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Have completed active primary treatment
* defined as surgery chemotherapy and/or radiation for the treatment of breast cancer
* Does not include immunotherapy or other targeted therapies such as trastuzumab, CDK 4/6 or mTOR inhibitors
Have been receiving AIs for at least 6 months prior to enrollment
Plan to continue AIs for an additional 3 months
Amenorrhea for at least 12 months at enrollment
Participants must be able to read and write in English
Participants must have \< 2% superficial vaginal cells on cytologic evaluation
You may not be if
Pre-existing hypertonic pelvic floor dysfunction identified in the medical record
Unresolved or recurrent vaginismus identified in the medical record
Aversion to touching one's own body, including genitals, or using vibration therapy on the genitals
Currently receiving estrogen therapy, including topical and/or systemic estrogens
Have received estrogen therapy within 6 months of study enrollment, including topical and/or systemic estrogens
Any surgical procedure to the vagina or vulva, excluding office biopsies, within the previous 12 months
Receipt of pelvic or vaginal or vulvar radiation therapy within the 12 months prior to enrollment or if the subject is anticipated to receive radiation targeted to any of these 3 locations within 6 months following enrollment
Any use of the VRP off study within the last 6 months
Clareo Health | Alterations in the Vaginal Microenvironment Using a Non-pharmacological Intervention
